{"data":{"id":"us-il/410-ilcs-416-20","jurisdiction":"us-il","citation":"410 ILCS 416/20","heading":"Requirements; notice.","body":"(a) The program:\n(1) must collaborate with physicians, health care providers, and clinical trial sponsors to notify a prospective subject about the program when:\n(A) the prospective subject consents to a clinical trial; or\n(B) funding is available to provide the program for the clinical trial in which the prospective subject participates;\n(2) must reimburse subjects based on financial need, which may include reimbursement to subjects whose income is at or below 700% of the federal poverty level;\n(3) must provide reimbursement for ancillary costs, including costs described under Section 15, to eliminate the financial barriers to enrollment in a clinical trial;\n(4) may provide reimbursement for reasonable ancillary costs, including costs described under Section 15, to one family member, friend, or other person who attends a clinical trial to support a subject; and\n(5) must comply with applicable federal and State laws.\n(b) The independent third-party organization administering the program shall provide written notice to prospective subjects of the requirements described under subsection (a).","path":["CHAPTER 410 PUBLIC HEALTH","Clinical Trial Participation Program Act."],"source_url":"https://www.ilga.gov/legislation/ILCS/details?ActID=4047\u0026ChapterID=35\u0026ChapAct=FullText\u0026Print=True","current_through":"at least Public Act 104-790","vintage":"","retrieved_at":"2026-09-15T04:46:35Z","sha256":"cca46a240f50fdd23de3c2bc7dd73448a577016bb322244fc5ad1b23ba349bb3","source_id":"us-il","stale":false,"prev":"us-il/410-ilcs-416-15","next":"us-il/410-ilcs-416-25"},"notice":"GroundRules: Original legal text. Not legal advice."}